Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) is focused on the vital role that industrial hemp will play in building a sustainable future. The company concentrates on the production and processing of hemp to produce raw and finished goods for domestic and international markets.
Through a series of partnerships, joint ventures and acquisitions, Global Hemp Group seeks to build a strategic portfolio of forward-thinking companies that also believe in the disruptive potential of the industrial hemp plant (http://cnw.fm/kd4OB). The company is headquartered in Vancouver, British Columbia, and is actively seeking additional projects in the hemp cultivation and cannabinoid extraction space in Canada and the United States.
Global Hemp Group, in partnership with Marijuana Company of America (OTC: MCOA), recently completed industrial hemp trials, in 2017, which marked the first hemp cultivation on the Arcadian Peninsula of New Brunswick, Canada in 20 years. The joint venture partners plan to begin commercial cultivation of industrial hemp in 2018, including plans to acquire equipment for the extraction of cannabinoids (CBD, CBG, CBN and CBC). Experienced hemp farmers have been recruited to grow on 125 acres in 2018, with plans to cultivate more than 1,000 acres by year three of the project. Global Hemp Group is to provide technical and management expertise to the joint venture.
What makes industrial hemp unique is its ample potential for aiding in the manufacture of thousands of sustainable products across a wide range of markets. To qualify as industrial hemp, regulation in the United States and Canada requires less than 0.3 percent Delta 9 Tetrahydrocannabinol (THC) content, the psychoactive ingredient in cannabis.
Hemp has tremendous value as an agricultural crop and industrial solution that can not only produce food and clothing on an industrial scale, but also has the potential to become the base product to develop, amongst other things, super-foods, textiles, building materials, bio-fuels and plant-based medicine. Oil-based products such as bio-plastics, cosmetics, sealants and cleaning products also provide an opportunity for hemp to find new global markets.
Industrial hemp plays a fundamental role in the development of sustainable industrial solutions. Global Hemp Group, with its knowledge and expertise, is building a strategic portfolio of companies with the objective of delivering shareholder value through joint ventures, partnerships and acquisitions.
For more information, visit the company’s website at www.GlobalHempGroup.com
More from PsychedelicNewsWire
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) PsychedelicNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, PNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. PNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, PNW brings its clients unparalleled visibility, recognition and brand awareness. PNW is where news, content and information converge.
For more information please visit https://www.psychedelicnewswire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/disclaimer/
PsychedelicNewsWire (PNW)
San Francisco, California
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com
The company targets all current ketamine indications, including anesthesia and pain management. The U.S. is…
The Kadima Neuropsychiatry Institute acquisition is part of NRx subsidiary HOPE Therapeutics’ model for a…
Subsidiary HOPE Therapeutics signed a $7.8 million debt financing term sheet with Universal Capital. Combined…
Kadima Neuropsychiatry Institute is expected to become the clinical model for HOPE Therapeutics’ nationwide network…
NRx Pharmaceuticals is advancing a pipeline of innovative therapies targeting multibillion-dollar unmet needs in central…
Rep. Morgan Luttrell (R-Texas), a retired Navy SEAL, is part of a rising wave of…